Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FT2MT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,346
Award facts
- Contract value 100% obligated
- $12,346.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,346.31 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 13, 2026, for the supply of Dupixent 300 mg/2 mL pen auto-injectors. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The order is expected to be completed by January 14, 2026, with performance occurring at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major pharmaceutical distributor serving federal healthcare systems, particularly those supporting military and veteran populations.
This delivery order is issued under AmerisourceBergen's parent company's Indefinite Delivery Contract with the DLA Troop Support Medical (valued at $999,999,999.00 through December 2031), which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to military healthcare programs globally. Dupixent is a prescription biologic medication used in the treatment of atopic dermatitis, eosinophilic esophagitis, and asthma, making this order consistent with the DLA's broader mission to support military treatment facilities and other federal medical institutions with essential pharmaceutical commodities across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FT2MT?
SPE2DR26FT2MT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FT2MT worth?
The government has obligated $12,346 on SPE2DR26FT2MT.
Is contract SPE2DR26FT2MT an order under another contract?
Yes. SPE2DR26FT2MT is a delivery order under SPE2DR25D3109, an indefinite delivery contract.
Was contract SPE2DR26FT2MT competed?
The extent of competition for SPE2DR26FT2MT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award